Engineering next-generation drug delivery platforms

The BioTranslation Lab (BTL) is a part of the Department of Anesthesiology and the Center for Nanomedicine at the Brigham and Women’s Hospital, Mass General Brigham, and Harvard Medical School, and  is affiliated with the Broad Institute of MIT and Harvard. Our goal is to develop translatable drug delivery technologies to address unmet clinical needs. Working at the interface of chemistry, material science, biology, and medicine, our highly interdisciplinary and collaborative research focuses on solving medical problems across a wide range of diseases, including arthritis, HIV, lung inflammation, and brain related disorders.